Literature DB >> 18242213

TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality.

Emiko Mizoguchi1, Yuriko Hachiya, Mayumi Kawada, Katsuya Nagatani, Atsuhiro Ogawa, Ken Sugimoto, Atsushi Mizoguchi, Daniel K Podolsky.   

Abstract

BACKGROUND & AIMS: Ligation of tumor necrosis factor (TNF) receptors (TNFRs) with TNF plays a critical role in the pathogenesis of human inflammatory bowel disease (IBD). However, it remains unclear which cell types activated through TNFR-associated signaling cascades are involved in the pathogenesis of colitis.
METHODS: Recombination activating gene-1 (RAG) knockout (KO) (no T or B cells)-based TNFR double and triple KO mice were generated. Bone marrow (BM) chimera mice in which BM-derived myeloid cells, but not colonic epithelial cells (CECs), express TNFRs were also generated. Colitis was induced by administration of dextran sodium sulfate (DSS) in distilled water. Murine lines and chimeras were assessed for disease severity, histopathology, apoptotic cell rate, epithelial proliferation, and bacterial invasion rate.
RESULTS: Following DSS administration, mice lacking both RAG and TNFR1 exhibited a high mortality (>80%) rate with an impaired CEC regeneration compared with RAG KO and RAG x TNFR2 double KO (DKO) mice. Transplantation of RAG KO-derived BM cells restored CEC regeneration and rescued the majority of recipient RAG x TNFR1 DKO mice from DSS-induced mortality. After BM transplantation, RAG x TNFR1 DKO mice exhibited an increased rate of apoptosis in the colonic lamina propria macrophages in association with the activation of caspases. In addition, BM reconstitution directly or indirectly enhanced the proliferation of CECs by activating mitogen-activated protein kinase and phosphoinositide-3 kinase/Akt pathways.
CONCLUSIONS: TNFR1-signaling cascade in colonic myeloid lineage cells contributes to the suppression of acute damage-associated mortality presumably by controlling CEC homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18242213     DOI: 10.1053/j.gastro.2007.11.055

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  25 in total

1.  Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.

Authors:  Jida Choi; Suyoung Bae; Jaewoo Hong; Soyoon Ryoo; Hyunjhung Jhun; Kwangwon Hong; Doyoung Yoon; Siyoung Lee; Erk Her; Wonhyuk Choi; Jeonghwan Kim; Tania Azam; Charles A Dinarello; Soohyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

2.  Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-κB/MAPKs Pathway.

Authors:  Huatuo Zhu; Shujun Huang; Min Yue; Wenguo Chen; Chao Lu; Xinhe Lou; Chunxiao Li; Guodong Shan; Hongtan Chen; Xiaowei Xu; Guoqiang Xu; Lihua Chen
Journal:  Dig Dis Sci       Date:  2018-06-29       Impact factor: 3.199

3.  Probiotics promote gut health through stimulation of epithelial innate immunity.

Authors:  Cristiano Pagnini; Rubina Saeed; Giorgos Bamias; Kristen O Arseneau; Theresa T Pizarro; Fabio Cominelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

4.  Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: insights from in vitro and in vivo experimental studies.

Authors:  Yoshiaki Hayashi; Kenta Narumi; Shigetsugu Tsuji; Toshinari Tsubokawa; Masa-aki Nakaya; Tomohiko Wakayama; Masahiko Zuka; Tohru Ohshima; Masakazu Yamagishi; Toshihide Okada
Journal:  Int J Colorectal Dis       Date:  2011-06-15       Impact factor: 2.571

5.  Chitin microparticles for the control of intestinal inflammation.

Authors:  Katsuya Nagatani; Sen Wang; Victoria Llado; Cindy W Lau; Zongxi Li; Atsushi Mizoguchi; Cathryn R Nagler; Yoshimi Shibata; Hans-Christian Reinecker; J Rodrigo Mora; Emiko Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2012-01-12       Impact factor: 5.325

6.  Tumor necrosis factor receptor 1 functions as a tumor suppressor.

Authors:  Fengqi Chang; Michelle R Lacey; Mostafa Bouljihad; Kerstin Höner Zu Bentrup; Ilana S Fortgang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-03       Impact factor: 4.052

7.  Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.

Authors:  Shivesh Punit; Philip E Dubé; Cambrian Y Liu; Nandini Girish; M Kay Washington; D Brent Polk
Journal:  Gastroenterology       Date:  2015-06-11       Impact factor: 22.682

Review 8.  Role of cytokines in inflammatory bowel disease.

Authors:  Fausto Sanchez-Munoz; Aaron Dominguez-Lopez; Jesus-K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

9.  TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.

Authors:  Liping Su; Sam C Nalle; Le Shen; Emily S Turner; Gurminder Singh; Lydia A Breskin; Ekaterina A Khramtsova; Galina Khramtsova; Pei-Yun Tsai; Yang-Xin Fu; Clara Abraham; Jerrold R Turner
Journal:  Gastroenterology       Date:  2013-04-22       Impact factor: 22.682

10.  Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.

Authors:  Masayuki Fukata; Yasmin Hernandez; Daisy Conduah; Jason Cohen; Anli Chen; Keith Breglio; Tyralee Goo; David Hsu; Ruliang Xu; Maria T Abreu
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.